Healthcare seeking among Swedish patients in opioid substitution treatment – a mixed methods study on barriers and facilitators

Troberg, Katja; Lundqvist, Karin; Hansson, Helena; Håkansson, Anders; Dahlman, Disa

doi:10.1186/s13011-022-00434-w

Cited by 6 publications

(3 citation statements)

References 66 publications

(77 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Despite safe and effective hepatitis C virus treatments in Norway [33], barriers often prevent those most in need from accessing them [3], necessitating further efforts. To improve outcomes when cancer has developed, health services should focus upon improving access to cancer treatment for people with opioid use‐related disorders and address potential barriers to care [34]. Health‐care providers should integrate cancer prevention, screening and access to treatment into routine care.…”

Section: Discussionmentioning

confidence: 99%

Increased cancer incidence and mortality among people with opioid use‐related disorders: A nation‐wide cohort study

Kostovski,

Hamina,

Hjellvik

et al. 2024

Addiction

View full text Add to dashboard Cite

Background and aimsStudies on cancer incidence and mortality among people with opioid use‐related disorders are lacking. We aimed to measure cancer‐specific incidence, mortality and survival among people diagnosed with opioid use‐related disorders in Norway during 2010–18.Design and settingThis was a cohort study conducted in Norway during 2010–18.ParticipantsIndividuals (n = 20 710) diagnosed with opioid use‐related disorders.MeasurementsWe conducted a cohort study utilizing a data‐linkage of national health and population registers. Information on opioid use‐related disorders was extracted from specialized healthcare, malignancies from the Cancer Registry of Norway and deaths from Cause of Death Registry. Cancer incidence and mortality were compared with the general population by calculating sex‐specific age‐standardized incidence (SIR) and mortality (SMR) ratios. One‐year survival rates were computed.FindingsCompared with the general population, people with opioid use‐related disorders were at an increased risk of developing cancer overall [SIR = 1.2, 95% confidence interval (CI) = 1.1–1.3] with a higher than twofold cancer mortality rate (SMR = 2.3, 95% CI = 2.0–2.7). Excess risk was observed for liver (12.6, 95% CI = 9.1–17.0), larynx (4.7, 95% CI = 1.7–10.2), lung (3.5, 95% CI = 2.8–4.3) and pancreas cancer (2.6, 95% CI = 1.6–4.0), whereas reduced risk was found for melanoma (0.5, 95% CI = 0.3–0.9), breast (0.6, 95% CI = 0.4–0.9) and prostate cancers (0.3, 95% CI = 0.1–0.4). Site‐specific SMRs were significantly elevated for liver (12.3, 95% CI = 8.5–17.2), lung (3.9, 95% CI = 3.0–5.0), pancreas (3.0, 95% CI = 1.7–4.8) and colon cancers (1.9, 95% CI = 1.1–3.1). The average 1‐year survival rate after a cancer diagnosis was low in liver, pancreas and colon cancer, ranging from 10 to 15% less than that of the general population.ConclusionsIn Norway, cancer incidence and cancer‐related mortality appear to be elevated among individuals with opioid use‐related disorders.

show abstract

Section: Discussionmentioning

confidence: 99%

Increased cancer incidence and mortality among people with opioid use‐related disorders: A nation‐wide cohort study

Kostovski,

Hamina,

Hjellvik

et al. 2024

Addiction

View full text Add to dashboard Cite

show abstract

“…Furthermore, individuals with OUD are over-represented in terms of acute health care utilization compared to the general population but may still be underserved in terms of their long-term somatic needs [ 17 , 18 ]. Patients also face barriers to seeking health care, such as stigma, which may negatively affect somatic health outcomes [ 19 ]. Patients in OMT report lower health-related quality of life [ 20 ], and somatic symptoms, such as pain, have been associated with medical and psychological comorbidities [ 21 , 22 ].…”

Section: Introductionmentioning

confidence: 99%

Change in self-reported somatic symptoms among patients in opioid maintenance treatment from baseline to 1-year follow-up

Bjørnestad,

Vederhus,

Clausen

2024

BMC Psychiatry

View full text Add to dashboard Cite

Background High somatic comorbidity is common among patients in treatment for opioid use disorder (OUD). The present study aims to investigate changes in self-reported somatic health conditions and somatic symptoms among patients entering opioid maintenance treatment (OMT) programs. Methods We used data from the Norwegian Cohort of Patients in OMT and Other Drug Treatment (NorComt) study. Of 283 patients who entered OMT, 176 were included for analysis at a 1-year follow-up. Participants provided self-reported data during structured interviews on somatic conditions, somatic symptoms, substance use severity measures, and mental distress. A multivariable linear regression analysis identified factors associated with changes in the burden of somatic symptoms. Results Patients entering OMT reported a high prevalence of somatic conditions at the beginning of treatment, with 3 of 5 patients reporting at least one. The most prevalent condition was hepatitis C, followed by asthma and high blood pressure. Patients reported experiencing a high number of somatic symptoms. The intensity of these symptoms varied across a wide spectrum, with oral health complaints and reduced memory perceived as the most problematic. Overall, for the entire sample, there was no significant change in somatic symptoms from baseline to 1 year. Further analysis indicated that those who reported a higher burden of somatic symptoms at baseline had the greatest improvement at the 1-year follow-up. A higher number of somatic conditions and higher mental distress at baseline was associated with improvements in somatic symptoms burden at follow-up. Conclusions Patients in OMT report a range of somatic conditions and somatic symptoms. Given the wide range of symptoms reported by patients in OMT, including some at high intensity levels, healthcare providers should take into consideration the somatic healthcare needs of individuals in OMT populations. Clinical trial registration Clinicaltrials.gov no. NCT05182918. Registered 10/01/2022 (the study was retrospectively registered).

show abstract

“…These barriers include long wait times for appointments or procedures, limited availability of healthcare providers, and complex referral processes (Devictor et al, 2023). In addition, deprioritization of medical care and judgment by clinicians can discourage individuals from seeking healthcare (Troberg et al, 2022).…”

Section: Healthcare Barriersmentioning

confidence: 99%

Understanding the acceptance of multisided teleconsultation platforms: a critical analysis and proposal of a theorical model

Galegale

View full text Add to dashboard Cite

I cannot thank enough Luis Hernan Contreras Pinochet, my co-advisor turned friend. When I could not find strength to continue, he did. After all the late nights collecting and analyzing data, discussing different theories, and going thru a whole crash course on new analytical methods. I can only hope to achieve such commitment and ethics. He is the real researcher super-star and I can only hope to continue this partnership for a very long time.I also thank the Business School of the University of São Paulo and its Post Graduate Department faculty for their support. I am grateful to all colleagues from the NETS USP research group for all their feedback and support, sharing their knowledge and challenges and always making sure to contribute. A special thanks to my close friend Fabiano Castello, who helped me with finding creative solutions to new problems. I thank my loving wife Anaira who supported me unconditionally and cheered each small milestone. Thank you for your love and strength to make sure I could focus and that our wonderful kids Napoleão and Vicente were always under the best care ever. Thanks to my brother Bernardo, who also shared the PhD journey and always kept me motivated.Finally, I thank my mother Yara and my father Napoleão who instilled in me the will to never stop asking questions and to work hard and smart. They are my constant inspiration to do better.

show abstract

Healthcare seeking among Swedish patients in opioid substitution treatment – a mixed methods study on barriers and facilitators

Cited by 6 publications

References 66 publications

Increased cancer incidence and mortality among people with opioid use‐related disorders: A nation‐wide cohort study

Increased cancer incidence and mortality among people with opioid use‐related disorders: A nation‐wide cohort study

Change in self-reported somatic symptoms among patients in opioid maintenance treatment from baseline to 1-year follow-up

Understanding the acceptance of multisided teleconsultation platforms: a critical analysis and proposal of a theorical model

Contact Info

Product

Resources

About